Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins

Author： Khrunin Andrey   Ivanova Feodosia   Moisseev Alexey   Khokhrin Denis   Sleptsova Yuliya   Gorbunova Vera   Limborska Svetlana  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.2, 2012-01, pp. : 171-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The antitumour activity of cisplatin-based chemotherapy for head and neck cancer is similar between young and elderly patients

By  

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of cisplatin-based chemoradiation in cervical cancer: a review

By Lappas Panos T   Rose Peter G  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1245-1249

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy

By García-Campelo Rosario   Alonso-Curbera Guillermo   Antón Aparicio LM   Rosell Rafael  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2015-2026

Informa Healthcare

Access to resources Recommend Favorite

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 124-133

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of platinum-based chemotherapy in NSCLC

By Hildebrandt Michelle AT   Gu Jian   Wu Xifeng  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite